PAD - Nursing Case Study
Pathophysiology
• Primary mechanism: Atherosclerosis is the primary cause of peripheral artery disease (PAD), where plaque build-up narrows and hardens arteries, reducing blood flow to the extremities. This leads to ischemia and results in pain and functional impairment, especially during physical activities like walking.
• Secondary mechanism: Endothelial dysfunction accompanies atherosclerosis, impairing the normal vasodilation response and further reducing blood supply. This dysfunction increases the risk of thrombosis, further exacerbating blood flow restriction.
• Key complication: Critical limb ischemia can occur as a severe complication, where inadequate blood supply causes severe pain, non-healing wounds, and can lead to tissue necrosis and possible amputation if not managed promptly.
Patient Profile
Demographics:
67 years old, female, retired school teacher
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia
• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing pain in the legs while walking
• Key symptoms: Intermittent claudication, numbness in the feet, cold extremities
• Vital signs: Blood pressure 150/92 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F
Section 1
New Complications:
As the patient's condition progresses, she begins to experience more pronounced symptoms indicative of advancing peripheral artery disease (PAD). In recent days, her intermittent claudication has intensified, and she reports persistent pain even at rest. Upon examination, new ulcers are noted on her right foot, particularly around the heel and the base of the toes, which appear to be slow-healing and show signs of potential infection, such as surrounding erythema and warmth. These ulcers suggest the onset of critical limb ischemia, a severe complication of PAD.
Laboratory tests reveal elevated inflammatory markers, with a C-reactive protein (CRP) level of 15 mg/L (normal <3 mg/L) and a white blood cell count of 12,000/mm³ (normal 4,500-11,000/mm³), indicating an inflammatory or infectious process. An ankle-brachial index (ABI) is performed, yielding a result of 0.5 for the right leg, confirming significant arterial insufficiency. Doppler ultrasound further demonstrates reduced blood flow to the affected limb, corroborating the clinical findings of severe ischemia.
These developments necessitate a reassessment of her management plan. The current medication regimen is reviewed, and the healthcare team considers the potential need for advanced interventions such as angioplasty or bypass surgery to restore adequate blood flow and prevent further tissue damage. Additionally, the possibility of starting antibiotic therapy is evaluated to address the potential infection of the foot ulcers. This situation requires close monitoring and coordination with vascular specialists to mitigate the risk of limb loss and improve the patient's quality of life.
Section 2
Change in Patient Status:
As the medical team implements the revised management plan, the patient's condition is closely monitored for any changes. Despite initial hopes for stabilization, the patient begins to exhibit signs of systemic involvement. Over the next 48 hours, she develops low-grade pyrexia, with temperatures fluctuating between 37.8°C and 38.2°C (100°F and 100.8°F), and reports increased fatigue. Her heart rate rises to 102 bpm, and her blood pressure drops slightly to 98/60 mmHg, raising concerns about the progression of her condition. These signs, coupled with her elevated inflammatory markers, suggest that the local infection in her foot ulcers may be advancing to a systemic level, potentially leading to sepsis if not addressed promptly.
The escalating symptoms prompt the healthcare team to prioritize intravenous antibiotic therapy, targeting both gram-positive and gram-negative organisms. Blood cultures are drawn to identify the causative pathogens and guide precise antibiotic treatment. Simultaneously, the vascular specialists discuss the urgency of revascularization procedures, such as angioplasty, to alleviate the severe ischemia contributing to ulcer deterioration. The team emphasizes the importance of strict glycemic control and nutritional support to enhance wound healing and overall recovery.
The patient's evolving status demands a multidisciplinary approach, integrating input from infectious disease specialists, vascular surgeons, and nursing staff to coordinate care effectively. Close monitoring of her vital signs, laboratory values, and ulcer healing progress becomes crucial as the team strives to prevent further complications and improve her prognosis. This situation underscores the need for timely intervention and comprehensive management to address both the local and systemic challenges posed by her advancing PAD.
Section 3
As the medical team continues to manage the patient's condition, new diagnostic results provide additional insights into her deteriorating status. Blood cultures return positive for Staphylococcus aureus, confirming the presence of a bacterial infection that aligns with the clinical signs of systemic involvement. The infection's identification guides the team to adjust the antibiotic regimen to a more targeted approach, using vancomycin to combat the gram-positive pathogen effectively. Despite this adjustment, the patient continues to exhibit signs of hemodynamic instability: her heart rate further increases to 110 bpm, and blood pressure remains low at 94/58 mmHg. Laboratory results reveal a white blood cell count of 14,000 cells/mm³ and a C-reactive protein level elevated to 120 mg/L, indicating ongoing inflammation and infection.
The nursing team conducts a thorough assessment, noting that the patient's foot ulcers have not shown marked improvement and remain a significant source of concern. The drainage appears purulent, and the surrounding tissue is erythematous and warm to the touch, suggesting persistent infection. Capillary refill time remains prolonged, and peripheral pulses are weak and thready, underscoring the critical need for revascularization. The patient's skin is pale and cool, and she reports increased pain and numbness in her lower extremities, consistent with worsening ischemia.
These findings necessitate an urgent interdisciplinary meeting to reassess the treatment strategy, with the vascular surgery team advocating for immediate angioplasty to restore adequate blood flow. Concurrently, the infectious disease specialists emphasize the need for continued aggressive antibiotic therapy and close monitoring for signs of sepsis. The nursing staff focuses on maintaining meticulous wound care and ensuring the patient's nutritional and fluid needs are met to support her body's fight against infection. The evolving scenario highlights the complexity of managing advanced PAD with systemic infection and the critical role of coordinated care in preventing further deterioration.
Section 4
As the interdisciplinary team implements the revised treatment plan, the nursing staff remains vigilant for any changes in the patient's condition. Despite the initiation of vancomycin and increased focus on wound care, the patient exhibits new signs of distress. Her temperature spikes to 38.9°C (102°F), and she becomes increasingly tachypneic with a respiratory rate of 28 breaths per minute. Oxygen saturation drops to 88% on room air, prompting the need for supplemental oxygen to maintain adequate levels. The patient appears more lethargic and confused, raising concerns about possible septic encephalopathy.
New laboratory results reveal a further increase in white blood cell count to 17,500 cells/mm³, coupled with a lactate level of 4.2 mmol/L, indicating a shift towards lactic acidosis. The combination of these findings suggests the development of septic shock, necessitating an escalation in care. The rapid response team is activated, and the patient is transferred to the intensive care unit for closer monitoring and management. Aggressive fluid resuscitation is initiated to address the hemodynamic instability, with the addition of vasopressors to maintain adequate blood pressure.
In the ICU, the medical team re-evaluates the patient's current treatment regime. With the persistent infection and signs of multi-organ involvement, the decision is made to broaden the antibiotic coverage temporarily while awaiting further culture results. The vascular surgeons remain on standby, as the patient's hemodynamic status must stabilize before proceeding with any invasive revascularization procedures. This critical juncture underscores the necessity of dynamic clinical reasoning and the integration of multidisciplinary expertise to navigate the complexities of her condition, aiming to prevent further deterioration and improve her chances for recovery.
Section 5
As the patient settles into the ICU, the interdisciplinary team prioritizes a comprehensive initial assessment to establish a baseline for ongoing monitoring. The patient's vital signs remain unstable, with a blood pressure of 86/54 mmHg despite fluid resuscitation and vasopressor support. Her heart rate is elevated at 115 beats per minute, and she continues to exhibit tachypnea with a respiratory rate of 30 breaths per minute. Oxygen saturation has improved to 92% with supplemental oxygen delivered via a non-rebreather mask. Neurologically, the patient is responsive to verbal stimuli but demonstrates persistent confusion, unable to recall recent events or follow complex commands, which is suggestive of worsening septic encephalopathy.
New diagnostic results reveal a significant renal impairment, with serum creatinine levels rising to 2.6 mg/dL, indicating acute kidney injury possibly secondary to septic shock and hypotension. Liver function tests show mildly elevated transaminases, hinting at potential hepatic involvement. Blood cultures remain pending, but preliminary imaging studies, including a chest X-ray, show bilateral infiltrates, raising the suspicion of a developing pulmonary infection or aspiration pneumonia, which could be contributing to her respiratory distress.
The medical team responds to these findings by intensifying renal monitoring, adjusting fluid management strategies to avoid further renal compromise, and considering the introduction of renal protective agents. The broad-spectrum antibiotic regimen is maintained, with close surveillance for any signs of clinical improvement or deterioration. The situation demands vigilant monitoring and timely interventions, as the team works to stabilize the patient while addressing the multifaceted aspects of her condition. This phase of care highlights the critical need for an agile and coordinated approach, integrating ongoing assessments and diagnostic data to guide treatment decisions and optimize patient outcomes.